Executive Management Corporate Governance

Anders Göransson

Employed 2021

Born: 1971

Education: MSc in Business, Uppsala University, Sweden and MBA Suffolk University, USA

Background: Various management positions within Amgen and broad consulting experience from McKinsey and Ernst & Young

Other assignments:

Shareholdings: 17 620 B shares as personal holdings and 432 277 call options

Stefan Grass
Chief Medical Officer and Deputy CEO

Employed 2019

Born: 1972

Education: MD PhD at Karolinska Institutet, Stockholm

Background: Specialist in anaesthesia and intensive care, Karolinska University Hospital. Medical officer, CSL Behring

Other assignments:

Shareholdings: 9,850 B shares as personal holdings and 28 818 call options

Carin Jakobson

Employed 2022

Born: 1974

Education: MSc in Economics Linnaeus University

Background: CFO positions at, among others, Stille, Sivers IMA and Rolling Optics

Other assignments:

Shareholdings: 144 092 call options

Carl Johan Fredin
Chief Licensing Officer

Employed 2021

Born: 1966

Education: MBA University of Stockholm

Background: Global Marketing Director Mölnlycke Health Care, Country Director Doro Care, Head of Sales and Marketing Mundipharma, Country Director Doro Care, Sales and Marketing Director Aleris, VD Orthocenter Göteborg/Malmö

Other assignments:

Shareholdings: 144 092 call options

Sathish Subramaniam
Chief Technology Officer

Employed 2013

Born: 1979

Education: BSc (Chemistry), University of Malaya & Master of Business Administration, Cardiff Metropolitan University, United Kingdom.

Background: Different managerial positions within Teleflex Medical and C.R. Bard.

Other assignments: Board member of Vigilenz Medical Devices Sdn Bhd and Vigilenz Medical Supplies Sdn Bhd.

Shareholdings: 144 092 call options

Peter Rådqvist
Global Head of Sales

Employed 2021

Born: 1967

Education: Bachelor’s degree in marketing, IHM Gothenburg

Background: Various Sales Manager positions within MedTech companies such as Straumann group, Biomet 3i (now part of Zimmer Biomet) and Dentsply.

Other assignments:

Shareholdings: 3,100 B shares as personal holdings and 144 092 call options

Fatima Stensvad Flodin
Chief Quality and Regulatory Officer

Employed 2021

Born: 1968

Education: Biochemistry and Molecular Biology – Bachelor degree

Background: Long experience from different managerial positions and consultancies within “Life Science”

Other assignments: –

Shareholdings: 14 409 B shares